Regards both to the high prevalence and associated prognosis of acute kidney injury in this setting7 and to the hormonal defect, arginine-vasopressin (AVP) could be used as preferential vasopressor agent by its action on smooth muscle cell. This evidence concerns the gene AVP and acute kidney injury.